Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12619000184178
ACTRN12619000184178
Not Yet Recruiting
N/A

Comparison of Immunogenicity of mOPV2 administered as 1-drop or 2-drop oral dose to infants in Mocuba district, Mozambique, 2019

WHO0 sites360 target enrollmentFebruary 8, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionspoliomyelitisInfection - Other infectious diseases

Overview

Phase
N/A
Intervention
Not specified
Conditions
poliomyelitis
Sponsor
WHO
Enrollment
360
Status
Not Yet Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 8, 2019
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
WHO

Eligibility Criteria

Inclusion Criteria

  • •healthy child between 9\-22 months of age living in study area

Exclusion Criteria

  • •residence outside of study area
  • •known immunodeficiency

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
Comparative evaluation of Immunogenicity of monovalent type 1 Oral Poliovirus Vaccine (mOPV1) and monovalent type 3 Oral Poliovirus Vaccine (mOPV3) versus trivalent Oral Poliovirus Vaccine (tOPV): a randomised double-blind controlled trial in South AfricaPoliomyelitisInfections and Infestations
ISRCTN18107202World Health Organization (WHO) (Switzerland)800
Completed
N/A
Comparative evaluation of immunogenicity of monovalent type 1 oral poliovirus vaccine (mOPV1) versus trivalent OPV (tOPV): a randomised double-blind trial set in EgyptPolioInfections and Infestations
ISRCTN76316509World Health Organization (WHO) (Switzerland)600
Completed
N/A
Comparative evaluation of immunogenicity of Monovalent Type 1 Oral Poliovirus Vaccine (mOPV1) versus trivalent OPV (tOPV): a randomised double-blind trial set in India (Panacea Biotec Ltd mOPV1 study)PolioInfections and Infestations
ISRCTN80143849Panacea Biotec Ltd (India)600
Not Yet Recruiting
Phase 4
Immune response to polio vaccine in malnourished and normally nourished Pakistani infantspolio vaccine immunogenecityInfection - Other infectious diseasesPublic Health - Other public health
ACTRN12612000259842WHO840
Not Yet Recruiting
Phase 4
Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional Dose Inactivated Poliovirus Vaccine in routine immunizatio
CTRI/2017/02/007793Panacea Biotec Ltd800